Pharmaceutical & BioTech
Discover all our Market Access services
Drug Development
Regulatory Affairs
Market Access
Pharmacovigilance
Quality & Compliance
Integrated strategy and execution in the European markets
A TOP-TIER CONSULTING NETWORK
RPN offers a well-coordinated European market access solution through its EU Network of highly-specialized consulting agencies with solid experience in delivering
a winning launch across Europe.
Its goal is to support international and ambitious healthcare clients who expect a fast and successful market access and pricing strategy for the launch of their innovative products in Europe.
SYNERGY FOR HTA REGULATION
Through the EU network, RPN combines in-depth knowledge about European market access requirements as well as about local markets and stakeholders.
Moreover, the new HTA regulation (applicable from January 2025) involves a joint clinical assessment at the European level but maintains pricing and reimbursement negotiations and decisions at national level.
This makes the synergies generated by the EU network of paramount importance.
